This new Liraglutide injection is a generic equivalent for Victoza, which is a once-daily noninsulin medicine that lowers ...

Already developing a trio of incretin drugs for obesity ... sidestep semaglutide – which is already approved as a weekly injection to treat obesity as Wegovy – and investigate the use of ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity ... Both of them are in the class of drugs known as incretin mimetics but have some differences.

Carmot’s other candidates include CT-868, a dual GLP-1/GIP agonist already in phase 2 testing as a once-daily injection to treat ... for this new generation of incretin-modulating obesity ...

“Overall, we are encouraged by our robust preclinical data package across four incretin-based molecules, which highlights the RaniPill® platform’s potential to effectively enable the oral ...